{
    "medicine_id": "c922795efb17aec51f954c98ac3d0b217a67130f",
    "platform_id": "DB05428",
    "metadata": {
        "name": "Adult Formula 50 60 61 v v Solution",
        "composition": "60 61 v v Motexafin gadolinium",
        "clinical_particulars": {
            "therapeutic_indications": "Investigated for use treatment in brain cancer cancer tumors unspecified lung cancer and lymphoma non hodgkin s",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "NA",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00012",
                        "description": "The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Motexafin gadolinium"
                    },
                    {
                        "drugbank-id": "DB00016",
                        "description": "The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Motexafin gadolinium"
                    },
                    {
                        "drugbank-id": "DB08894",
                        "description": "The risk or severity of Thrombosis can be increased when Peginesatide is combined with Motexafin gadolinium"
                    },
                    {
                        "drugbank-id": "DB09107",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Motexafin gadolinium"
                    },
                    {
                        "drugbank-id": "DB00707",
                        "description": "Motexafin gadolinium may increase the photosensitizing activities of Porfimer sodium"
                    },
                    {
                        "drugbank-id": "DB00460",
                        "description": "Motexafin gadolinium may increase the photosensitizing activities of Verteporfin"
                    },
                    {
                        "drugbank-id": "DB00755",
                        "description": "The risk or severity of adverse effects can be increased when Tretinoin is combined with Motexafin gadolinium"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}